PRME
Prime Medicine Inc.
$4.99
+$0.10(+2.04%)
83
Overall
--
Value
83
Tech
--
Quality
Market Cap
$628.46M
Volume
2.42M
52W Range
$1.11 - $5.20
Target Price
$6.78
EPS Estimates Overview
| Current Quarter | $-0.28 | Next Quarter | $-0.24 |
| Current Year | $-1.23 | Next Year | $-0.96 |
| QoQ Growth | +14.3% | YoY Growth | +22.0% |
| 3Y EPS CAGR | +37.3% | Target Price | $6.78 |
| Consensus | Buy | Upside | +35.9% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRME | $4.99 | +2.0% | 2.42M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |